Patent · US Active

Synthetic viruses and uses thereof

US9765304B2 · kind B2 · utility

7Cited by
10References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 24, 2014
Grant dateSep 19, 2017
Priority date
Expiry dateJan 24, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2810/6072
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells and uses thereof. This invention more particularly relates to compositions and methods of using a synthetic viral particle to produce, modify or regulate an immune response in a subject. In a more preferred embodiment, the invention is based, generally, on compositions using synthetic viral particles as an adjuvant and/or vehicle to raise an immune response against selected antigen(s) or epitopes, in particular a cellular and/or a humoral immune response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.